This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $560,694 to the University of Wisconsin - Madison to conduct research on the role of the growth differentiation factor 15 (GDF15) in the failure to thrive phenotype associated with Alexander disease, a severe neurodegenerative disorder. The research aims to determine if increased GDF15 levels, promoted by the astrocyte stress response, induce nausea and anorexic behavior that contribute to the failure to thrive seen in this disease. The project will measure GDF15 levels in animal models and human patients, explore the relationship between the integrated stress response and GDF15 expression, and evaluate whether blocking GDF15 or its receptor can mitigate the failure to thrive phenotype. The award period runs from July 1, 2025 to June 30, 2026.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $560.7k | 6/25/25 |